GKOS.K

GKOS.K has a market price of $134.92, resulting in a market capitalization of $7.92 billion. The company's price-to-book ratio is 12.08, and its price-to-tangible-book ratio is also 12.08, indicating a premium valuation relative to its book value. The enterprise value to EBITDA ratio is negative at -39.59, reflecting the company's current operating losses. The enterprise value to revenue ratio is 15.57, suggesting a moderate valuation relative to its revenue. In terms of profitability, GKOS.K has a return on equity of -28.6% and a return on assets of -21.01%, both of which are significantly below industry norms and indicate poor performance. The company's gross profit margin is 78.0%, which is relatively high, but this is offset by a negative operating margin of -3.9% and a net margin of -3.7%. These metrics suggest that while the company is generating substantial gross profits, it is unable to convert these into operating or net profits. Geographically, GKOS.K's revenue is concentrated in the United States, with no significant international exposure disclosed in the available data. The company's revenue is primarily derived from its core healthcare services and equipment business, with no material diversification into other segments. Looking at the company's growth trajectory, GKOS.K has reported a revenue of $507.44 million in the latest period. However, the company is currently experiencing negative operating and net income, with operating income at -$19.96 million and net income at -$187.69 million. The company's free cash flow is also negative at -$171.39 million, indicating that it is not generating sufficient cash to fund its operations and capital expenditures. The capital expenditure for the period is -$24.27 million, suggesting that the company is investing in its operations. In terms of risk, GKOS.K has a low liquidity risk, with a current ratio of 4.69, indicating that it has sufficient current assets to cover its current liabilities. The company's debt-to-equity ratio is 0.11, suggesting a conservative capital structure with minimal leverage. The risk assessment indicates a low dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's liquidity position is supported by $90.81 million in cash and equivalents. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's operating cash flow is negative at -$14.79 million, which is consistent with its negative net income. The company's total assets are $893.49 million, and its total liabilities are $237.33 million, resulting in a total equity of $656.16 million. The company's long-term debt is $69.46 million, which is relatively low compared to its total equity.